FDA Adverse Event Summary report: N

MEDRAD CONTINUUM MR COMPATIBLE INFUSION DEVICE

MDR report key: 4931785 · Received July 22, 2015

Report

Report Number
2520313-2015-00039
Date Received
July 22, 2015
Date of Event
May 28, 2015
Report Date
June 29, 2015
Manufacturer
BAYER MEDICAL CARE, INC.
Product Code
FRN
PMA / PMN Number
K021988
Removal / Correction Number
605-2013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

THE SITE PLACED THE CONTINUUM MR INFUSION PUMP UNDER QUARANTINE IMMEDIATELY FOLLOWING THE REPORTED INCIDENT. MULTIPLE DOCUMENTED ATTEMPTS WERE MADE TO HAVE THE CONTINUUM PUMP RETURNED TO BAYER MEDICAL CARE, INC. FOR EVALUATION, AS WELL AS, TO GAIN SPECIFIC INFORMATION RELATED TO THE REPORTED EVENT WITH NO SUCCESS. BASED ON THE LIMITED INFORMATION, WE WERE UNABLE TO DETERMINE THE ROOT CAUSE OF THE ALLEGED MEDICATION OVER INFUSION. IN THE EVENT ADDITIONAL INFORMATION IS OBTAINED, A FOLLOW-UP REPORT WILL BE SUBMITTED. IN (B)(4) 2014, BAYER HEALTHCARE ANNOUNCED A DECISION TO PERMANENTLY REMOVE THE CONTINUUM MR INFUSION SYSTEM FROM THE FIELD WITHOUT REPLACEMENT (FDA # (B)(4)). THE DECISION TO REMOVE THE PRODUCT FROM THE FIELD WAS OFFICIALLY COMMUNICATED TO THIS CUSTOMER IN WRITING ON (B)(6) 2014. AFTER FAILING TO RECEIVE A RESPONSE FROM THE CUSTOMER, FOLLOW UP LETTERS WERE SENT ON (B)(6) 2015 AND THEN AGAIN ON (B)(6) 2015.

Description of Event or Problem · 1

ON (B)(4) 2015, WE RECEIVED A COPY OF MEDWATCH, UF/IMPORTER # (B)(4). THE CUSTOMER REPORTED THAT AN ALLEGED OVER INFUSION OF TISSUE PLASMINOGEN ACTIVATOR (TPA) HAD OCCURRED WHILE A PATIENT WAS CONNECTED TO A CONTINUUM MR INFUSION SYSTEM. IN THIS REPORT IT WAS STATED THAT "PUMP MAY HAVE BEEN PROGRAMMED INCORRECTLY. NO PATIENT HARM OCCURRED."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
474539 MEDRAD CONTINUUM MR COMPATIBLE INFUSION DEVICE INFUSION PUMP FRN BAYER MEDICAL CARE, INC. 3015725

Patients

Seq Age Sex Outcome Treatment
1 Other